NEWMarkets
Lenz Therapeutics (LT) Stock Price Target Cut to $48 by H.C. Wainwright
Published on 4/21/2026
AI Summary
H.C. Wainwright has lowered the stock price target for Lenz Therapeutics (LT) to $48. This revision reflects adjustments in market expectations for the company's growth and profitability. Analysts often use price targets to indicate potential investment value and shifts in market sentiment toward a stock. The change in target could influence investor decisions, potentially impacting Lenz Therapeutics' trading volume and market position.
